What is the Share Price of Themis Medicare Ltd?
- Answer Field
-
The share price of Themis Medicare Ltd for NSE is ₹ 128.1 and for BSE is ₹ 127.85.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, THEMIS MEDICARE LTD. share price is currently at ₹ 128.1, which is down by ₹ -2.86 from its previous closing. Today, the stock has fluctuated between ₹ 127.52 and ₹ 131.92. Over the past year, THEMIS MEDICARE LTD. has achieved a return of -41.42 %. In the last month alone, the return has been -12.81 %. Read More...
Particulars | DEC 2024 (Values in Cr) |
---|---|
Revenue | 93.81 |
Operating Expense | 90.61 |
Net Profit | 3.08 |
Net Profit Margin (%) | 3.28 |
Earnings Per Share (EPS) | 0.33 |
EBITDA | 9.55 |
Effective Tax Rate (%) | 27.01 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 19.60 | 1.99 | 279.41 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 119.00 | 15.60 | 1.24 | 1253.91 | 92.25 / 184.95 |
CIPLA LTD | 1549.65 | 25.08 | 4.41 | 125155.99 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 260.70 | 21.60 | 2.64 | 767.27 | 145.00 / 449.00 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 21.96 | 6.19 | 279.41 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 692.80 | 40.61 | 6.72 | 2002.93 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 8665.50 | 129.24 | 31.88 | 21663.75 | 5000.00 / 9199.00 |
BLISS GVS PHARMA LTD | 119.00 | 15.45 | 1.22 | 1253.91 | 92.25 / 184.95 |
Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969. The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993. Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001. The Group is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.
In Mar.'95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital.
Total cost of the project was estimated at Rs 17.64 cr. TCL manufactures and sells synthetic bulk drugs and formulations. It operates in the therapeutic segments of anti-tuberculosis, cerebroactivators, bronchodilators, anti-asthmatic, anaesthetic and other segments.
Anti-tuberculosis bulk drugs and formulations account for 60% of its turnover and the company is rated fourth in terms of turnover in this segment. TCL has also started manufacturing and exporting fumagillin, an anti-bacterial drug, for veterinary use for which it has a confirmed buy-back arrangement with Chinoin, Hungary.
The company with the help of M/s Pharmograd,Moscow a manufacturing unit, is planning to market its Anti-T.B.formulation products through the collborators throughout the Russian Federation for trade,tenders and govt.supplies.
The Company introduced products like Cardiac and Muscular Relaxant during the year 2001-02. A wholly owned subsidiary of the Company, Themis Medicare Singapore Pte. Ltd., formed on 22nd May, 2002 in Singapore became operational during the year 2002-03.
M/s. Artemis Biotech Ltd., a Group Company was merged with Themis Medicare Ltd. (the Parent Company) with effect from 1st April 2003. The Joint Venture Company, 'Richter Themis Medicare (India) Pvt. Ltd.' started manufacturing activities at its EOU unit at Vapi effective from March, 2006. The Company started operations of its new Injection Plant at Haridwar for tablets and gel formulation production in 2006-07. 'Themiseal', the Company's unique haemostatic and anti-microbial product was launched in the UK, Greece, Cyprus, Jordan, Romania and Indonesia.
During the year 2010-11, a Private Ltd Subsidiary Company in the name and style of Themis Lifestyle Pvt. Ltd was incorporated on 3rd November, 2010 and another Public Ltd Subsidiary Company in the name and style of Artemis Biotech Ltd. was incorporated on 14th January, 2011.
During FY 2016-17, HID-PUL KFT (Hungary), a Wholly Owned Subsidiary of the Company, ceased to be a subsidiary of the Company. 'Carpo Medical Limited' was incorporated as a Joint Venture Company in the United Kingdom in 2016-17.
The Company launched a new product - Lenzetto Global brand of Estradiol Novel Drug Delivery System for treatment of Menopausal symptoms in 2023. As part of a strategy to concentrate on both the API and the Hospital Business, the Company demerged the API segment of the Company, including both the API production facilities, to a 100% owned subsidiary company, Themis Lifestyle Private Limited through slump sale in 2023.
The share price of Themis Medicare Ltd for NSE is ₹ 128.1 and for BSE is ₹ 127.85.
The market cap of Themis Medicare Ltd for NSE is ₹ 11,79.03 Cr. and for BSE is ₹ 11,76.73 Cr. as of now.
The 52 Week High and Low of Themis Medicare Ltd for NSE is ₹ 317.00 and ₹ 115.00 and for BSE is ₹ 313.65 and ₹ 115.05.
You can trade in Themis Medicare Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been -41.42%.
Themis Medicare Ltd share price is for NSE ₹ 128.1 & for BSE ₹ 127.85 as on Apr 30 2025 03:29 PM.
The market cap of Themis Medicare Ltd for NSE ₹ 11,79.03 & for BSE ₹ 11,76.73 as on Apr 30 2025 03:29 PM.
As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Themis Medicare Ltd share is 34.26.
As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Themis Medicare Ltd share is 31.70.
You can trade in Themis Medicare Ltd shares with Bajaj Broking by opening a demat account.
To buy Themis Medicare Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Themis Medicare Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found